GCL SI Delivers Marine Floating Solar Solution in the Maldives, Enabling Island Energy Transition

GCL SI Delivers Marine Floating Solar Solution in the Maldives, Enabling Island Energy Transition

SUZHOU, China, Jan. 19, 2026 /PRNewswire/ -- GCL System Integration (GCL SI) has announced the successful completion of the joint floating solar energy project in collaboration with long-term partner Ocean Sun for the Soneva Secret resort in...

GAC Energy Releases 2025 EV Charging Ecosystem Report: Over 23,000 Self-Operated Charging Piles Across China

GAC Energy Releases 2025 EV Charging Ecosystem Report: Over 23,000 Self-Operated Charging Piles Across China

GUANGZHOU, China, Jan. 17, 2026 /PRNewswire/ -- Recently, GAC Energy has released its 2025 Ecological Service Report, highlighting strong advances in ultra-fast charging technology, nationwide network deployment, and V2G innovation under the GAC...

The AKG and Ca-AKG of Xin Tianhe have passed the US Self-GRAS certification

The AKG and Ca-AKG of Xin Tianhe have passed the US Self-GRAS certification

SHENZHEN, China, Jan. 16, 2026 /PRNewswire/ -- On January 7, 2026, the AKG and Ca-AKG of Xin Tianhe Biotechnology successfully completed the Self-GRAS scientific evaluation in accordance with the US FDA GRAS standards and were approved and became...

H.I.G. Capital Announces Closing of Oversubscribed European Lower Middle Market Private Equity Fund

H.I.G. Capital Announces Closing of Oversubscribed European Lower Middle Market Private Equity Fund

MIAMI, Jan. 15, 2026 /PRNewswire/ -- H.I.G. Capital ("H.I.G." or the "Firm"), a leading global alternative asset management firm with $74 billion of capital under management, today announced the final closing of H.I.G. Europe Capital Partners IV...

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

AIM's Iterative Process High-Efficiency Diploid Rabies Vaccine Completes Phase III Clinical Trials, Efficacy Significantly Higher than Existing Market Products

HONG KONG, Jan. 15, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully completed...

Eastern International Ltd. Completed Two Major Offshore Wind Power Projects and Secured an Additional Large-Scale Offshore Transportation Contract for Yangjiang Project

Eastern International Ltd. Completed Two Major Offshore Wind Power Projects and Secured an Additional Large-Scale Offshore Transportation Contract for Yangjiang Project

HANGZHOU, China, Jan. 14, 2026 /PRNewswire/ -- Eastern International Ltd. ("Eastern International" or the "Company") (NASDAQ: ELOG), a provider of domestic and cross-border professional logistic services and construction services including project...

SeeTrue AI screening solution becomes the first and only to receive ECAC certification for Automated Prohibited Items Detection (APIDS)

SeeTrue AI screening solution becomes the first and only to receive ECAC certification for Automated Prohibited Items Detection (APIDS)

ECAC's recognition marks a major leap towards automated, regulatory-approved screening operations. TEL AVIV, Israel, Jan. 8, 2026 /PRNewswire/ -- SeeTrue AI, a global leader in AI-powered security screening, is proud to announce that its SeeTrue...

CHAGEE Releases "2025 Year-End Tea Friends Review": Global Stores Span 8 Countries Across 2 Continents, Annual Tea Procurement Exceeds 10,000 Tons

CHAGEE Releases "2025 Year-End Tea Friends Review": Global Stores Span 8 Countries Across 2 Continents, Annual Tea Procurement Exceeds 10,000 Tons

SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- On January 8, 2026, CHAGEE released its 2025 Year-End Tea Friends Review. The Review outlines the company's growth over the past year, with its store network now operating in eight countries across two...

Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring

Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring

SHANGHAI, Dec. 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Phase II clinical trial of its self-developed innovative anti-IL-11 monoclonal...

TGE Executes SPA for New York Tribeca Hotel Successfully

TGE Executes SPA for New York Tribeca Hotel Successfully

PARIS and NEW YORK and LONDON, Dec. 26, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE: TGE; LSE: TGE), a subsidiary of AMTD...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 17
  • menu
    menu